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Abstract
Background
Regular fish and omega-3 consumption may have several health benefits and are recom-
mended by major dietary guidelines. Yet, their intakes remain remarkably variable both
within and across populations, which could partly owe to genetic influences.
Objective
To identify common genetic variants that influence fish and dietary eicosapentaenoic acid
plus docosahexaenoic acid (EPA+DHA) consumption.
Design
We conducted genome-wide association (GWA) meta-analysis of fish (n = 86,467) and EPA
+DHA (n = 62,265) consumption in 17 cohorts of European descent from the CHARGE
(Cohorts for Heart and Aging Research in Genomic Epidemiology) Consortium Nutrition
Working Group. Results from cohort-specific GWA analyses (additive model) for fish and
EPA+DHA consumption were adjusted for age, sex, energy intake, and population stratifica-
tion, and meta-analyzed separately using fixed-effect meta-analysis with inverse variance
weights (METAL software). Additionally, heritability was estimated in 2 cohorts.
Results
Heritability estimates for fish and EPA+DHA consumption ranged from 0.13–0.24 and 0.12–
0.22, respectively. A significant GWA for fish intake was observed for rs9502823 on chromo-
some 6: each copy of the minor allele (FreqA = 0.015) was associated with 0.029 servings/
day (~1 serving/month) lower fish consumption (P = 1.96x10-8). No significant association
was observed for EPA+DHA, although rs7206790 in the obesity-associated FTO gene was
among top hits (P = 8.18x10-7). Post-hoc calculations demonstrated 95% statistical power
to detect a genetic variant associated with effect size of 0.05% for fish and 0.08% for EPA
+DHA.
Genome-wide association of dietary fish and EPA+DHA consumption
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Conclusions
These novel findings suggest that non-genetic personal and environmental factors are prin-
cipal determinants of the remarkable variation in fish consumption, representing modifiable
targets for increasing intakes among all individuals. Genes underlying the signal at
rs72838923 and mechanisms for the association warrant further investigation.
Introduction
Consumption of fish (including finfish and shellfish) and long-chain omega-3 fatty acids is
linked to lower risk of several chronic diseases, in particular fatal coronary heart disease [1].
These beneficial associations in observational studies are supported by randomized controlled
trials demonstrating favorable effects of fish or fish oil on numerous chronic disease risk fac-
tors and on cardiac mortality [1,2]. As a result, regular fish consumption is recommended by
all major national and international dietary guidelines [1].
In contrast to these guidelines and in comparison to many other foods, remarkable varia-
tion exists in the amount of fish consumption within and across populations. In many Western
nations, approximately one-third of individuals consume no fish at all, approximately one-
third consume fish but relatively rarely (up to once per week), and approximately one-third
consume fish more frequently [3]. While some of this wide variation in fish consumption is
undoubtedly due to personal and environmental factors (e.g., culture, geographic residence,
family habits, socioeconomic status), the potential contribution of intrinsic biologic factors,
such as genetic variation, is not well established. In one analysis among Danish twins, the esti-
mated heritability of fish consumption was 17% in men and 61% in women, based on additive
genetic effects [4]. For example, potential heritability could relate to differences in genes
related to taste, digestion, fatty acid metabolism, or other unknown processes related to food
preferences. Yet, the potential genetic variants underlying this estimated heritability are
unknown; and such heritability estimates also require further replication.
A basic concept underlying “personalized nutrition” is that a person’s genes can influence
their behaviors and responses to the environment. Dietary habits, including the consumption
of fish, are among the most relevant factors that influence the development of chronic diseases.
Elucidating whether, and in what manner, specific genes alter fish and long-chain omega-3
fatty acid consumption would have implications for understanding influences on variation in
fish intake within populations and the biology of partiality to foods. Furthermore, identifica-
tion of such variants could also inform the development of personalized nutrition—dietary
recommendations based on genetic preferences for consumption.
As has been seen with other characteristics such as physiologic risk factors, genome-wide
association (GWA) studies may lead to discovery of novel genes and biologic pathways that
influence the individual characteristic of interest. Although such studies have been performed
for major macronutrients (e.g., fat, carbohydrate, protein) [5,6], few analyses have been done
for specific foods[7], whose intakes may be influenced by complex characteristics of tastes, tex-
tures, aromas, and nutrient contents. The ability to undertake food-specific genetic analyses
has been limited by the modest sample sizes of individual cohorts having both dietary and
genetic information and the potential lack of reproducibility of genetic findings discovered in
any single cohort.
We therefore performed a collaborative investigation to estimate heritability of and assess
how common genetic variation relates to dietary consumption of both fish and long-chain
omega-3 fatty acids (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) as part of
Genome-wide association of dietary fish and EPA+DHA consumption
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Subjects and methods
Cohorts
The present work was a collaboration among 17 US and European population-based cohort
studies participating in the Nutrition Working Group of the CHARGE Consortium (S1
Table). These included the Atherosclerosis Risk in Communities Study (ARIC); Cardiovascu-
lar Health Study (CHS); Dietary, Lifestyle, and Genetic Determinants of Obesity and Meta-
bolic Syndrome (DILGOM); Estonian Study; Family Heart Study (FamHS); Framingham
Heart Study (FHS); Helsinki Birth Cohort Study (HBCS); Health 2000 survey (H2000); Health,
Aging, and Body Composition (HealthABC) Study; Health Professionals Follow-up Study
(HPFS); Invecchiare [Aging] in Chianti Area (InCHIANTI); Multi-Ethnic Study of Athero-
sclerosis (MESA); Nurses’ Health Study (NHS); Rotterdam Study; The Hellenic Study of Inter-
actions between SNPs and Eating in Atherosclerosis Susceptibility (THESIAS); Women’s
Genome and Health study (WGHS); and Young Finns Study (YFS). Additional details on
these cohorts have been published previously [5,6] and are provided in S1 Table. All persons
studied were of European descent, consented to genetic research, and provided written
informed consent. For each study, examination protocols were approved by local institutional
review boards at Johns Hopkins University (ARIC, MESA), University of Washington (CHS),
Epidemiology and Public Health of the Hospital District of Helsinki and Uusimaa (DILGOM),
Washington University (FamHS), Boston University (FHS), University of Pittsburgh
(HealthABC), Harvard University (HPFS, NHS), National Public Health Institute of Finland
(HBCS), Epidemiology and Public Health of the Hospital District of Helsinki and Uusimaa
(H2000), Italian National Institute of Research and Care of Aging (InCHIANTI), Erasmus
Medical Center and The Netherlands Ministry of Health, Welfare and Sports (Rotterdam),
Harokopio University (THESIAS), Brigham and Women’s Hospital (WGHS), University of
Helsinki (YFS), and procedures were in accordance with the ethical standards of the responsi-
ble institutional or regional committee on human subject research.
Assessment of fish and omega-3 fatty acid consumption
Usual dietary intake was assessed in each cohort using detailed food frequency questionnaires
designed to capture the dietary habits of the population under study (S2 Table). Typically, par-
ticipants were asked to indicate how often, on average, they had consumed various foods and
beverages over the past year according to multiple frequency categories (e.g., 9 categories rang-
ing from <1/month to 6+/day), with usual portion sizes specified on the questionnaire or by
the participant. Fish intake was generally assessed using multiple questions, such as on con-
sumption of tuna fish; dark meat fish such as salmon or sardines; other white fish; shellfish;
and fried fish or fish sandwiches. For each question, the midpoint of each frequency category
was used to estimate usual intake which was then multiplied by the specified portion size;
these intakes were summed across all questions on fish. For this analysis, we standardized fish
consumption in each cohort to 100g servings/day. In 12 cohorts, total dietary consumption of
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) was estimated by linking the
dietary assessment tool to a food composition table specific to the cohort (e.g., the USDA food
composition database in the US). For each of the types of foods consumed, the frequency and
average portion size were multipled by the content of EPA/DHA in the food. The total was cal-
culated by summing across all foods in the questionnaire. For cohorts that included nutrients
Genome-wide association of dietary fish and EPA+DHA consumption
PLOS ONE | https://doi.org/10.1371/journal.pone.0186456 December 13, 2017 4 / 15
NIH, National Institute on Aging contracts
N01AG62101, N01AG62103, and N01AG62106.
The genome-wide association study was funded by
NIA grant R01 AG032098 to Wake Forest
University Health Sciences and genotyping
services were provided by the Center for Inherited
Disease Research (CIDR). CIDR is fully funded
through a federal contract from the National
Institutes of Health to The Johns Hopkins
University, contract number
HHSN268200782096C. The use of Health 2000
data in this study has been financially supported by
the Academy of Finland (grant 250207) and Orion-
Farmos Research Foundation. The authors would
like to thank the many colleagues who contributed
to collection and phenotypic characterization of the
clinical samples, and DNA extraction and
genotyping of the data, especially Eija Ha¨ma¨la¨inen,
Minttu Jussila, Outi To¨rnwall, Pa¨ivi Laiho, and the
staff from the Genotyping Facilities at the
Wellcome Trust Sanger Institute. They would also
like to acknowledge those who agreed to
participate in the H2000 study. Invecchiare in
Chianti (aging in the Chianti area, InCHIANTI) study
investigators thank the Intramural Research
Program of the NIH, National Institute on Aging
who are responsible for the InCHIANTI samples.
Investigators also thank the InCHIANTI
participants. The InCHIANTI study baseline (1998-
2000) was supported as a “targeted project”
(ICS110.1/RF97.71) by the Italian Ministry of
Health and in part by the U.S. National Institute on
Aging (Contracts: 263 MD 9164 and 263 MD
821336). The Multi-Ethnic Study of Atherosclerosis
(MESA) and MESA SHARe project are conducted
and supported by contracts N01-HC-95159
through N01-HC-95169 and RR-024156 from the
National Heart, Lung, and Blood Institute (NHLBI).
Funding for MESA SHARe genotyping was
provided by NHLBI Contract N02-HL-6-4278. The
authors thank the participants of the MESA study,
the Coordinating Center, MESA investigators, and
study staff for their valuable contributions. A full list
of participating MESA investigators and institutions
can be found at http://www.mesa-nhlbi.org. The
NHS and HPFS are supported by the National
Cancer Institute (NHS: UM1 CA186107, HPFS:UM1
CA167552) with additional support for genotyping.
The NHS Breast Cancer GW scan was performed
as part of the Cancer Genetic Markers of
Susceptibility initiative of the NCI (R01CA40356,
U01-CA98233). The NHS/HPFS type 2 diabetes
GWAS (U01HG004399) is a component of a
collaborative project that includes 13 other GWAS
funded as part of the Gene Environment-
Association Studies (GENEVA) under the NIH
Genes, Environment and Health Initiative (GEI)
from supplements, the portion of EPA+DHA from supplements was excluded from our
analysis.
Heritability estimates
To evaluate potential heritability of fish and EPA+DHA consumption, we estimated heritabil-
ity using family-based methods in two family-based cohorts (FamHS and FHS) using the vari-
ance components method in Sequential Oligogenic Linkage Analysis Routines (SOLAR; Texas
Biomedical Research Institute; San Antonio, TX), and adjusting for age and sex. Briefly, herita-
bility is calculated using a maximum likelihood method using the ratio of the genetic variance
to total phenotypic variance.[8]
Genotyping and analysis
Genome-wide genotyping was conducted in each cohort using Affymetrix or Illumina plat-
forms. Each study performed quality control for genotyped single nucleotide polymorphisms
(SNPs) based on minor allele frequency (MAF), call rate, and departure from Hardy-Weinberg
equilibrium (S3 Table). Phased haplotypes from HapMap CEU were used to impute ~2.5 mil-
lion autosomal SNPs using a Hidden Markov Model algorithm implemented in MACH,
IMPUTE, or BimBam. Study-specific GWA analyses were conducted within each cohort using
genotyped and imputed SNP dosages assuming an additive genetic model. Fish and EPA
+DHA consumption were separately evaluated as the dependent variable using linear regres-
sion with robust standard error, adjusted for age, sex, energy intake (kcal/d), study-specific
centers where applicable, and population stratification principal components when the cohort
lambda was >1. SNPs with low MAF (<1%), low imputation quality (MACH: R2<0.3; or
IMPUTE: proper info <0.4), were excluded. Quality control for cohort-level GWAS results
was performed to ensure correct specification of the minor allele and agreement in frequencies
with the reference population (HapMap CEU), consistent distribution of effect sizes and stan-
dard error, and examination of QQ plots to assess any large inflation of test statistics. Results
across studies were combined using fixed-effect meta-analysis with inverse variance weights
(METAL software)[9]. The association results from individual studies as well as meta-analyses
were adjusted for genomic control. To explore potential heterogeneity by demographic region,
a meta-analysis within cohorts from Europe and USA was performed. Genome-wide signifi-
cance was considered at the Bonferroni-corrected threshold of P<5x10-8. Statistical power to
detect a true association at various effect sizes (heritability) was calculated using GWAPower
software for the analysis of 1 million independent SNPs for both fish and EPA+DHA (Feng S,
2011 BMC Genetics), assuming linkage disequilibrium (r2) of 0.5 between a SNP and putative
causal variant and 10% variance explained by three covariates.
Exploratory analysis of plasma phospholipid EPA and DHA
Result from genome-wide association analyses of circulating EPA and DHA are publically
available (http://faculty.washington.edu/rozenl/files/) [10]. These databases were mined to test
whether the top SNPs from the fish and EPA+DHA intake GWAS are associated with circulat-
ing levels of EPA and DHA.
Results
The 17 cohorts were from the US, Estonia, Finland, Greece, Italy, and the Netherlands and
included 86,467 participants with information on fish consumption and 62,265 with information
on EPA+DHA consumption. Across participating cohorts, mean fish consumption ranged from
Genome-wide association of dietary fish and EPA+DHA consumption
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0.19 servings/day (FHS) to 0.75 servings/day (THISEAS) (Table 1). Mean intake of EPA+DHA
consumption ranged from 89 (Rotterdam) to 563 (HBCS) mg/d and was generally consistent
with findings on fish intake, except in THISEAS (Greece) which had relatively higher intakes of
fish than EPA+DHA, suggesting predominant consumption of white (non-oily) fish. In general,
participants in European cohorts had higher fish consumption than those in US cohorts.
The heritability estimates for fish intake were 0.13±0.03 (FamHS) and 0.24±0.02 (FHS); and
for EPA+DHA intake, 0.12±0.03 (FamHS) and 0.22±0.02 (FHS). In GWA meta-analyses of fish
(17 cohorts) and EPA+DHA (11 cohorts) consumption, the genomic control lambda values
were 1.07 and 0.99 respectively (S1 and S2 Figs). A genome-wide significant association was
observed for fish intake on chromosome 6 for rs9502823 (Table 2). The minor allele (FreqA =
0.015) was associated with 0.029 servings/day lower fish consumption (P = 1.96x10-8). This SNP
was mapped to LOC285768 gene of unknown function (Fig 1, top panel); and was not identified
in NHGRI-EBI GWAS catalogue (http://www.ebi.ac.uk/gwas/, search on Feb 23, 2017). The sec-
ond top hit was rs17396472 on chromosome 3, not achieving genome-wide statistical signifi-
cance (P = 5.62x10-8).
No genome-wide significant association was observed for EPA+DHA consumption (S1
and S2 Figs). The top association for EPA+DHA consumption was observed for rs11877506
(P = 1.18x10-7) (Table 2). Additionally, rs7206790 in the obesity-associated FTO gene was
among the top SNPs for EPA+DHA intake: the body mass index-raising G allele was associ-
ated with 7mg/day greater EPA+DHA intake (Fig 1, bottom panel; P = 7.44x10-7).
To obtain more information on the locus associated with fish consumption on chromo-
some 6, we investigated data from the ENCODE project. Using CEU 1000genomes data, we
calculated the LD within the region 250kb upstream and downstream from rs9502823. Map-
ping the SNPs found in the rs9502823 LD block to ENCODE regulatory regions, we identified
rs72838923 (in complete LD with rs9502823) as a functional candidate. rs72838923 falls within
a experimentally determined H3k27Ac region, identified in several cell types in ENCODE.
H3k27Ac regions are thought to be markers of active enhancer activity. In addition,
rs72838923 falls within DNAse Hypersensitivity Peak which were identified experimentally
across 65 cell types from the ENCODE project. There is further evidence of transcription fac-
tor binding sites for FOXA1, among others in this region, from ENCODE CHIP-Seq experi-
ments. In addition, mapping rs72838923 on the UCSC genome browser suggested that this
SNP is found within a region of conservation across mammals.
Due to the varying ranges of average fish consumption in US versus European studies, we
performed exploratory subgroup GWA meta-analysis stratified by geographic location. No sig-
nificant associations were identified in USA nor European studies (S3 Fig) for fish or EPA
+DHA consumption (S4 Fig).
A prior consortium analysis including several of these same cohorts reported on genome-
wide association of SNP variants with plasma phospholipid EPA and DHA, the concentrations
of which are determined by both dietary intake and endogenous metabolism regulation.[11]
In exploratory analysis, we evaluated whether the top 5 hits for fish consumption and the top 4
hits for estimated dietary EPA+DHA consumption identified in the present analysis were asso-
ciated with plasma phospholipid concentrations of EPA or DHA in that prior analysis [10],
adjusting for multiple comparisons (9 SNPs x 2 fatty acids = Bonferroni-corrected alpha of
0.05/18 = 0.0028). No significant associations were identified (S4 Table).
Discussion
In this large GWA meta-analysis of 17 US and European cohorts totaling 86,467 participants,
we found evidence that common genetic variation may be associated with consumption of
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fish. We found no genome-wide significant association of common variants with EPA+DHA
intake. While the sample size for the analysis of EPA+DHA was smaller than the fish intake
analysis, with 62,265 individuals the analysis had 95% power to detect an effect size (heritabil-
ity) of 0.08%.
We identified one locus on chromosome 6 in association with fish consumption. The SNP
was mapped to LOC285768with unknown function. The next closest gene is forkhead box Q1
(FOXQ1) which is a member of the cancer-associated forkhead-box (FOX) gene family [12].
Our evaluation of data from ENCODE, taken together, identified a functional candidate,
rs72838923, that appears to lie within a transcriptionally active region of the genome. While
the association was statistically significant, the magnitude of effect was small, with the minor
allele being associated with a difference of 0.03 servings/day or approximately 1 serving/month
of fish. This finding is more likely to be relevant for understanding the biology of food prefer-
ences than for influencing clinical outcomes, although even small differences in fish consump-
tion, over a lifetime, could influence health. The nonsignificant top associations identified in
chromosomes 1, 3, and 12 each represent intragenic regions of genes highly expressed in the
brain, but these associations did not achieve genome-wide significance.
In heritability analyses, we found evidence for modest heritability of fish (0.13 to 0.24) and
EPA+DHA (0.12 to 0.22). Our GWA results identified one locus in association with fish intake
that cannot fully account for this observed heritability, suggesting that observed heritability
might be due to remarkably small effects across a large number of SNPs, other types of genetic
Table 1. Characteristics of the cohorts included in this analysis of the genetics of fish consumption.
Study Maximum
N
Age % Female Total Fish Intake (serv/day)
Median (5-95th%)
Dietary EPA+DHA (mg/d)
Median (5-95th%)
ARIC 9557 54.3 ± 5.7 53 0.21 (0.0–0.9) 180 (10–730)
CHS 3190 72.3 ± 5.4 61 0.29 (0.1–0.8) 191 (27–569)
DILGOM_METABO 3467 51.5 ± 13.4 55 0.42 (0.1–1.3) 431 (119–1277)
DILGOM_GWA 604 52.4 ± 13.5 52 0.44 (0.1–1.2) 444 (107–1233)
ESTONIAN Study 9920 48.8 ± 20.1 53 0.21 (0.0–0.6) - -
FamHS 3640 52.2 ± 13.7 53 0.14 (0.0–0.7) 170 (1–680)
FHS 7044 47.3 ± 11.8 54 0.13 (0.0–0.6) 200 (40–640)
Health ABC 1494 74.8 ± 2.9 48 0.20 (0.2–0.3) - -
Health 2000 1935 50.5 ± 10.9 51 0.39 (0.1–1.1) 505 (102–1477)
HBCS 1701 61.5 ± 2.9 57 0.44 (0.1–1.3) 563 (145–1895)
HPFS 4133 58.6 ± 8.7 0 0.29 (0.1–0.9) - -
InCHIANTI 1194 68.3 ± 15.4 55 0.19 (0.0–0.5) - -
MESA 2305 62.7 ± 10.2 52 0.17 (0.0–0.7) 100 (20–300)
NHS 6776 54.4 ± 6.7 100 0.28 (0.1–0.8) - -
Rotterdam 4606 67.6 ± 7.7 59 0.07 (0.0–0.5) 89 (8–443)
THISEAS 395 59.4 ± 13.0 41 0.59 (0.0–2.0) 137 (4–479)
WGHS 22691 54.7 ± 7.1 100 0.20 (0.0–0.7) 150 (30–470)
YFS 1815 37.8 ± 5.0 56 0.34 (0.1–0.9) 357 (92–902)
Abbreviations: Atherosclerosis Risk in Communities Study (ARIC); Cardiovascular Health Study (CHS); Dietary, Lifestyle, and Genetic Determinants of
Obesity and Metabolic Syndrome (DILGOM); Estonian Study; Family Heart Study (FamHS); Framingham Heart Study (FHS); Helsinki Birth Cohort Study
(HBCS); Health 2000 survey (H2000); Health, Aging, and Body Composition (HealthABC) Study; Health Professionals Follow-up Study (HPFS);
Invecchiare [Aging] in Chianti Area (InCHIANTI); Multi-Ethnic Study of Atherosclerosis (MESA); Nurses’ Health Study (NHS); Rotterdam Study; The
Hellenic Study of Interactions between SNPs and Eating in Atherosclerosis Susceptibility (THESIAS); Women’s Genome and Health study (WGHS); and
Young Finns Study (YFS).
https://doi.org/10.1371/journal.pone.0186456.t001
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Abbreviations: EPA, eicosapentaenoic acid; DHA,
docosahexaenoic acid; LD, linkage disequilibrium;
GWAS, genome-wide association study.
variation such as copy number variants, epigenetic modifications, or multiple unobserved
genetic interactions with unknown environmental factors. This challenge of “missing” or
unaccounted for heritability is a frequent finding in GWA analyses of common diseases and
traits [13]. Heritability analyses may overestimate heritability due to unmeasured shared envi-
ronmental influences, for example from in utero/placental influences through childhood and
adult life. In this light, our heritability findings are lower than those previously reported [4]
and represent an additional important new contribution. Our findings support the need for
future investigations of the possible explanations for the modest but as yet missing heritability
of fish and EPA+DHA consumption.
This investigation had several strengths. Our pooling of multiple large, well-established
cohorts provided a very large sample of participants for investigating our research questions.
Our post-hoc power calculations demonstrate 95% statistical power to detect a genetic variant
associated with an effect size of 0.05% for fish consumption and 0.08% for EPA+DHA con-
sumption. We adjusted for total reported energy intake, which helps to address any systematic
over- or under-reporting by individuals and also real differences in total food consumed (i.e.,
due to differences in age, sex, body size, or physical activity), facilitating evaluation of dietary
composition. All the studies in the meta-analysis used comparable dietary assessment tools
that were appropriate for the population under study, providing the highest quality data that
can be reasonably collected across multiple large epidemiological studies.
Limitations should be considered. While dietary intakes assessed by food frequency ques-
tionnaire represent a reasonably valid method to collect data on usual dietary habits in large
populations [14], such data also include measurement error, which could limit the ability to
detect true associations. However, many validation studies have demonstrated that fish and
EPA+DHA consumption are measured reasonably well by food frequency questionnaires,
whether compared with multiple diet records or with objective circulating or tissue biomarkers
[15,16,17,18]. Indeed, because biomarker levels also represent imperfect measures of “true”
habitual consumption with uncorrelated errors compared to questionnaire estimates, the
actual correlations of estimated fish or EPA+DHA consumption with “true” consumption are
likely much higher, in the range of 0.8 or more. Compared with a candidate gene approach,
GWA has lower statistical power to detect small genetic effects. Yet, candidate gene approaches
for evaluating fish consumption would be strongly limited by imperfect knowledge of which
genes affect known systems and biologic processes related to food preferences and, even more
so, which genes may affect currently unknown systems and biologic influences on food
preferences.
In summary, this large pooling project across 17 established cohorts identified modest heri-
tability of fish and omega-3 fatty acid consumption and one genetic locus associated with fish
Table 2. The most significant associations from genome-wide association meta-analysis of fish and EPA+DHA consumption.
Trait SNPID Chr Position N Effect/ Non-effect Freq (Effect) Effect StdErr P-value
Fish Intake rs9502823 6 1050674 71910 A/G 0.02 -0.029 0.005 1.96E-08
(serving/day) rs17396472 3 68469758 63102 A/T 0.98 0.031 0.005 5.62E-08
rs1860343 12 4583970 78153 T/C 0.52 -0.006 0.001 4.30E-07
rs1562806 15 35038800 61909 T/C 0.94 0.022 0.004 1.41E-06
rs16834168 1 150754770 77898 A/G 0.02 -0.020 0.004 1.58E-06
EPA+DHA rs11877506 18 49176846 52909 A/G 0.96 16.313 3.091 1.18E-07
(mg/day) rs2456163 19 1427432 36937 T/C 0.04 -15.560 3.087 4.20E-07
rs7476409 10 24809042 52909 T/C 0.05 -17.907 3.589 5.50E-07
rs7206790 16 52355409 56099 C/G 0.55 -7.000 1.420 7.44E-07
https://doi.org/10.1371/journal.pone.0186456.t002
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consumption. These findings suggest that genetic variation may have small effects on fish con-
sumption and, by extension, that other modifiable factors–for example, childhood diet, cul-
ture, education, income, and local availability–are the main determinants of the remarkable
differences in fish consumption within and across populations, representing targets for
increasing fish intake among all individuals.
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